Literature DB >> 17900992

Pregabalin-induced generalized myoclonic status epilepticus in patients with chronic pain.

S Knake1, K M Klein, K Hattemer, A Wellek, W H Oertel, H M Hamer, F Rosenow.   

Abstract

Pregabalin is often used for the treatment of chronic pain syndromes. We here describe two patients with chronic pain and pregabalin-induced myoclonic status epilepticus. Patients treated with pregabalin who experience sudden behavioral changes or mycloni should be investigated for this possible side effect, and pregabalin should be reduced or discontinued if myocloni or status epilepticus occurs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900992     DOI: 10.1016/j.yebeh.2007.06.012

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  8 in total

1.  Delayed onset of rotatory self-motion perception, dysdiadochokinesia and disturbed eye pursuit caused by low-dose pregabalin.

Authors:  Patrice Hounnou; Keyvan Nicoucar
Journal:  BMJ Case Rep       Date:  2014-04-11

2.  [Non-convulsive status epilepticus: temporary fad or reality in need of treatment?].

Authors:  F Rosenow; S Knake; H M Hamer
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

3.  Pregabalin as adjunctive therapy in adult and pediatric patients with generalized tonic-clonic seizures: A randomized, placebo-controlled trial.

Authors:  Joseph Driscoll; Mary Almas; Gabriela Gregorian; Alla Kyrychenko; Iryna Makedonska; Jing Liu; Jeffrey Patrick; Joseph M Scavone; Jeremias Antinew
Journal:  Epilepsia Open       Date:  2021-05-16

4.  Myoclonic status epilepticus in six patients without epilepsy.

Authors:  Leyla Baysal Kirac; Ibrahim Aydogdu; Ahmet Acarer; Sezin Alpaydin; Fatma Ece Bayam; Habibe Onbasi; Fikret Bademkiran
Journal:  Epilepsy Behav Case Rep       Date:  2012-11-07

5.  Nonconvulsive Status Epilepticus Resembling Clinical Absence with Atypical EEG Pattern.

Authors:  Channaiah Srikanth Mysore; Najib Murr; Rana Zabad; John Bertoni
Journal:  Case Rep Neurol Med       Date:  2017-01-19

6.  Current awareness: pharmacoepidemiology and drug safety.

Authors: 
Journal:  Pharmacoepidemiol Drug Saf       Date:  2008-06       Impact factor: 2.890

7.  Negative myoclonus associated with pregabalin.

Authors:  Kwan-Do Park; Min-Ku Kim; Se-Jin Lee
Journal:  Yeungnam Univ J Med       Date:  2018-12-31

8.  Treatment of Super-Refractory Status Epilepticus: A Review.

Authors:  Juan G Ochoa; Michelle Dougherty; Alex Papanastassiou; Barry Gidal; Ismail Mohamed; David G Vossler
Journal:  Epilepsy Curr       Date:  2021-03-10       Impact factor: 7.500

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.